![]() Fusion Pharmaceuticals Fusion Pharmaceuticals is a clinical-stage biopharmaceutical company developing targeted alpha-particle radiotherapeutics for treating cancer. | ![]() Prelude Therapeutics Prelude Therapeutics is a biotechnology company that discovers and develops medicines targeting chromatin function to treat cancer and rare diseases. | ![]() Cullgen Cullgen is a biotech drug discovery company dedicated to the development of targeted protein degraders. | |
Founding Date | Founding Date 2014 | Founding Date 2016 | Founding Date 2018 |
Type | Type Subsidiary | Type Private | Type Private |
Tags | |||
Locations | Locations Hamilton, CA HQ Boston, US | Locations Wilmington, US HQ Canton, US | Locations San Diego, US HQ Shanghai, CN Tokyo, JP |
Employees | Employees 101 | Employees 1372% decrease | Employees 4 |
Funding | |||
Latest funding round | Latest funding round N/A | Latest funding round $ 50m (almost 6 years ago) | Latest funding round $ 16m (about 7 years ago) |
Total funding raised | Total funding raised $ 170.9m | Total funding raised $ 122m | Total funding raised $ 31m |

Prelude Therapeutics is a biotechnology company that discovers and develops medicines targeting chromatin function to treat cancer and rare diseases.
View company
Cullgen is a biotech drug discovery company dedicated to the development of targeted protein degraders.
View company